Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6

1.

Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice.

Lefterov I, Fitz NF, Cronican AA, Fogg A, Lefterov P, Kodali R, Wetzel R, Koldamova R.

J Biol Chem. 2010 Nov 19;285(47):36945-57. doi: 10.1074/jbc.M110.127738. Epub 2010 Aug 25.

2.

Cerebral amyloid angiopathy and dementia.

Tian J, Shi J, Mann DM.

Panminerva Med. 2004 Dec;46(4):253-64. Review.

PMID:
15876981
3.

Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.

Dewachter I, van Dorpe J, Spittaels K, Tesseur I, Van Den Haute C, Moechars D, Van Leuven F.

Exp Gerontol. 2000 Sep;35(6-7):831-41. Review.

PMID:
11053674
4.

Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques.

Kumar-Singh S.

Genes Brain Behav. 2008 Feb;7 Suppl 1:67-82. doi: 10.1111/j.1601-183X.2007.00380.x. Review.

5.

Physiological functions of APP family proteins.

Müller UC, Zheng H.

Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006288. doi: 10.1101/cshperspect.a006288. Review.

6.

Outcome markers for clinical trials in cerebral amyloid angiopathy.

Greenberg SM, Al-Shahi Salman R, Biessels GJ, van Buchem M, Cordonnier C, Lee JM, Montaner J, Schneider JA, Smith EE, Vernooij M, Werring DJ.

Lancet Neurol. 2014 Apr;13(4):419-28. doi: 10.1016/S1474-4422(14)70003-1. Epub 2014 Feb 27. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk